Literature DB >> 22960341

The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.

Sanaa Eissa1, Soheir Badr, Shadia Abd Elhamid, Azza Salah Helmy, Mohamed Nour, Mohamed Esmat.   

Abstract

OBJECTIVE: In a trial to improve the diagnostic efficacy of conventional urine cytology we determine survivin RNA and matrix metalloproteinase 2 and 9 in urine of bladder cancer cases.
METHOD: Voided urine specimens were collected from patients with histologically confirmed bladder urothelial carcinoma (Group 1; n=46), urological patients without urothelial carcinoma (Group 2; n=20), and healthy volunteers (Group 3; n=20). Urine cytology, survivin RNA was estimated by qualitative nested RT-PCR and MMP-2, MMP-9 activity were detected by gelatin zymography. The expression of survivin RNA and matrix metalloproteinase 2 and 9 in bladder cancer was compared with benign and normal cases.
RESULTS: Positivity rates of survivin RNA and MMPs zymography were significantly different among the 3 groups. Urine survivin detection by qualitative nested RT-PCR showed 76.1% sensitivity and 95% specificity. The overall sensitivity, specificity of urinary MMP zymography was 67.3%, 90% respectively. The combined use of urine cytology with urine survivin or MMPs zymography increased sensitivity of urine cytology from 50% to 84.7%. The highest sensitivity (95.6%) was obtained on combining the three markers.
CONCLUSION: Survivin RNA and MMPS zymography can be considered as promising noninvasive markers for bladder cancer early detection. Combined use of the three markers improved the sensitivity for detecting bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22960341      PMCID: PMC3810229          DOI: 10.3233/DMA-2012-0923

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  6 in total

1.  Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.

Authors:  Zhenzhen Liang; Rui Xin; Yinghui Yu; Rui Wang; Chunpeng Wang; Xin Liu
Journal:  World J Urol       Date:  2018-04-02       Impact factor: 4.226

2.  Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.

Authors:  Juliane Schmidt; Catharina Propping; Woei-Yun Siow; Andrea Lohse-Fischer; Marieta Toma; Anka Baldauf-Twelker; Oliver W Hakenberg; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-02       Impact factor: 4.553

3.  Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.

Authors:  Fan-Chang Zeng; Song Cen; Zheng-Yan Tang; Xin-Li Kang
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

Review 4.  The promise of novel molecular markers in bladder cancer.

Authors:  Jahan Miremami; Natasha Kyprianou
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

5.  Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.

Authors:  Liang Fu; Jiwang Zhang; Ling Li; Yuxing Yang; Yongqiang Yuan
Journal:  Oncol Lett       Date:  2019-12-18       Impact factor: 2.967

6.  Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy.

Authors:  Dahai Dong; Yu Yao; Jinlei Song; Lijiang Sun; Guiming Zhang
Journal:  Dis Markers       Date:  2021-05-25       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.